Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with <i>IL1A</i> and <i>TNFSF10</i>
Authors: Charbonneau Bridget , Block Matthew S. , Bamlet William R. , Vierkant Robert A. , Kalli Kimberly R. , Fogarty Zachary , Rider David N. , Sellers Thomas A. , Tworoger Shelley S. , Poole Elizabeth , Risch Harvey A. , Salvesen Helga B. , Kiemeney Lambertus A. , Baglietto Laura , Giles Graham G. , Severi Gianluca , Trabert Britton , Wentzensen Nicolas , Chenevix-Trench Georgia , Whittemore Alice S. , Sieh Weiva , Chang-Claude Jenny , Bandera Elisa V. , Orlow Irene , Terry Kathryn , Goodman Marc T. , Thompson Pamela J. , Cook Linda S. , Rossing Mary Anne , Ness Roberta B. , Narod Steven A. , Kupryjanczyk Jolanta , Lu Karen , Butzow Ralf , Dörk Thilo , Pejovic Tanja , Campbell Ian , Le Nhu D. , Bunker Clareann H. , Bogdanova Natalia , Runnebaum Ingo B. , Eccles Diana , Paul James , Wu Anna H. , Gayther Simon A. , Hogdall Estrid , Heitz Florian , Kaye Stanley B. , Karlan Beth Y. , Anton-Culver Hoda , Gronwald Jacek , Hogdall Claus K. , Lambrechts Diether , Fasching Peter A. , Menon Usha , Schildkraut Joellen , Pearce Celeste Leigh , Levine Douglas A. , Kjaer Susanne Kruger , Cramer Daniel , Flanagan James M. , Phelan Catherine M. , Brown Robert , Massuger Leon F.A.G. , Song Honglin , Doherty Jennifer A. , Krakstad Camilla , Liang Dong , Odunsi Kunle , Berchuck Andrew , Jensen Allan , Lubiński Jan , Nevanlinna Heli , Bean Yukie T. , Lurie Galina , Ziogas Argyrios , Walsh Christine , Despierre Evelyn , Brinton Louise , Hein Alexander , Rudolph Anja , Dansonka-Mieszkowska Agnieszka , Olson Sara H. , Harter Philipp , Tyrer Jonathan , Vitonis Allison F. , Brooks-Wilson Angela , Aben Katja K. , Pike Malcolm C. , Ramus Susan J. , Wik Elisabeth , Cybulski Cezary , Lin Jie , Sucheston Lara , Edwards Robert , McGuire Valerie , Lester Jenny , du Bois Andreas , Lundvall Lene , Wang-Gohrke Shan , Szafron Lukasz M. , Lambrechts Sandrina , Yang Hannah , Beckmann Matthias W. , Pelttari Liisa M. , Van Altena Anne M. , van den Berg David , Halle Mari K. , Gentry-Maharaj Aleksandra , Schwaab Ira , Chandran Urmila , Menkiszak Janusz , Ekici Arif B. , Wilkens Lynne R. , Leminen Arto , Modugno Francesmary , Friel Grace , Rothstein Joseph H. , Vergote Ignace , Garcia-Closas Montserrat , Hildebrandt Michelle A.T. , Sobiczewski Piotr , Kelemen Linda E. , Pharoah Paul D.P. , Moysich Kirsten , Knutson Keith L. , Cunningham Julie M. , Fridley Brooke L. , Goode Ellen L. 
Published: April 2023

<p>PDF file - 145K, Supplementary Table 1. Studies in the Ovarian Cancer Association Consortium (OCAC) are listed, as well as the abbreviation, location, type, and number of cases and controls for each study. Supplementary Table 2. The number of cases included in the analysis from each OCAC study site is listed by histologic subtype. Supplementary Table 3. Gene symbols and IDs are listed for NF-κB pathway genes that were tagged in this study, as well as chromosome position, number of SNPs tagged, and bin coverage of each gene using Hapmap or 1000 genomes as a reference. Supplementary Table 4. Reasons and numbers of samples excluded from the analysis following the sample quality control are described. Supplementary Table 5. We evaluated rs17561 and rs6785617 for interactions with known epidemiologic risk factors for risk of clear cell and LMP tumors, respectively, and report interaction p-values in the table below.</p>